| Full Name | Wei He |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 11 Years |
| Location | 507 Park Grove Dr, Katy, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437492451 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | T8224 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hermann Katy Hospital | Katy, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mhs Physicians Of Texas | 1557254968 | 71 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that Schering-Plough HealthCare Products, Inc., the consumer healthcare subsidiary of Merck & Co., Inc., has commenced promotion of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its licensing agreement with Santarus for the over-the-counter (OTC) market in North America. The OTC heartburn market in the U.S. is estimated at approximately $1.8 billion based on data from market research firm Information Resources, Inc. and Santarus estimates.
Republican Senator Richard Lugar of Indiana reintroduced legislation last month to cut $40 billion from federal farming support and federal nutrition assistance funding, which could eliminate food stamps for 74,000 already hungry Illinois residents, including 15,000 in Chicago.
Rigel Pharmaceuticals, Inc. today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product candidates. R343 is an inhaled SYK inhibitor that is being evaluated as a potential treatment for allergic asthma.
Gilead Sciences, Inc. today announced that the company has signed a definitive agreement under which Gilead will purchase a clinical biologics manufacturing facility and certain process development assets located in Oceanside, California from Genentech, a member of the Roche Group.
› Verified 2 days ago
| Entity Name | Mhs Physicians Of Texas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184714867 PECOS PAC ID: 1557254968 Enrollment ID: O20040207000177 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that Schering-Plough HealthCare Products, Inc., the consumer healthcare subsidiary of Merck & Co., Inc., has commenced promotion of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its licensing agreement with Santarus for the over-the-counter (OTC) market in North America. The OTC heartburn market in the U.S. is estimated at approximately $1.8 billion based on data from market research firm Information Resources, Inc. and Santarus estimates.
Republican Senator Richard Lugar of Indiana reintroduced legislation last month to cut $40 billion from federal farming support and federal nutrition assistance funding, which could eliminate food stamps for 74,000 already hungry Illinois residents, including 15,000 in Chicago.
Rigel Pharmaceuticals, Inc. today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product candidates. R343 is an inhaled SYK inhibitor that is being evaluated as a potential treatment for allergic asthma.
Gilead Sciences, Inc. today announced that the company has signed a definitive agreement under which Gilead will purchase a clinical biologics manufacturing facility and certain process development assets located in Oceanside, California from Genentech, a member of the Roche Group.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wei He, MD 507 Park Grove Dr, Katy, TX 77450-1759 Ph: (281) 206-2127 | Wei He, MD 507 Park Grove Dr, Katy, TX 77450-1759 Ph: (281) 206-2127 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that Schering-Plough HealthCare Products, Inc., the consumer healthcare subsidiary of Merck & Co., Inc., has commenced promotion of ZEGERID OTC™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its licensing agreement with Santarus for the over-the-counter (OTC) market in North America. The OTC heartburn market in the U.S. is estimated at approximately $1.8 billion based on data from market research firm Information Resources, Inc. and Santarus estimates.
Republican Senator Richard Lugar of Indiana reintroduced legislation last month to cut $40 billion from federal farming support and federal nutrition assistance funding, which could eliminate food stamps for 74,000 already hungry Illinois residents, including 15,000 in Chicago.
Rigel Pharmaceuticals, Inc. today announced that it has commenced Phase 2 clinical studies with two of the company's most advanced proprietary therapeutic product candidates. R343 is an inhaled SYK inhibitor that is being evaluated as a potential treatment for allergic asthma.
Gilead Sciences, Inc. today announced that the company has signed a definitive agreement under which Gilead will purchase a clinical biologics manufacturing facility and certain process development assets located in Oceanside, California from Genentech, a member of the Roche Group.
› Verified 2 days ago
Dr. Justin Patrick Morgan, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 23900 Katy Fwy Ste 450, Katy, TX 77494 Phone: 713-486-7980 Fax: 713-486-8085 | |
Dr. Ankit Ashwin Patel, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 507 Park Grove Ln, Katy, TX 77450 Phone: 281-206-2127 Fax: 281-206-2322 | |
Dr. Brian Zachariah, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 24275 Katy Fwy Ste 410, Katy, TX 77494 Phone: 877-504-8504 Fax: 855-420-6402 | |
Adenike Adigun, M.D, MPH Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 24275 Katy Fwy Ste 410, Katy, TX 77494 Phone: 877-504-8504 Fax: 855-420-6402 | |
Dr. Melissa Sue Jones, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 24514 Kingsland Blvd, Katy, TX 77494 Phone: 832-471-6248 Fax: 832-471-6984 | |
Ramana Surya, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 24530 Kingsland Blvd Ste B, Katy, TX 77494 Phone: 832-321-5180 Fax: 832-321-4497 | |
Dr. Jontel D Pierce, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2043 N Mason Rd Ste 704, Katy, TX 77449 Phone: 281-402-9522 |